Dyne Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise By Underwriters Of Option To Purchase Additional Shares

WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing i

Related Keywords

New York ,United States ,San Francisco ,California ,Amy Reilly ,Raymond James ,Equity Syndicate Prospectus Department ,Oppenheimer Co ,Dyne Therapeutics Inc ,Equity Syndicate Department ,Exchange Commission ,Guggenheim Securities ,Nasdaq ,Morgan Stanley ,Morgan Stanley Co ,Prospectus Department ,Nicolaus Company Incorporated ,One Montgomery Street ,